Maternal and cord C5a in response to eculizumab Response

被引：4
作者：
Burwick, Richard M. [1 ]
Burwick, Nicholas [2 ]
Feinberg, Bruce B. [3 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Portland, OR 97239 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[3] Columbia Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, New York, NY USA
来源：
BLOOD | 2015年 / 126卷 / 02期
关键词：
COMPLEMENT ACTIVATION; PREGNANCY; AHUS;
D O I：
10.1182/blood-2015-06-642553
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 280
页数：4
相关论文
共 8 条
[1]   Eculizumab for the treatment of preeclampsia/HELLP syndrome [J].
Burwick, R. M. ;
Feinberg, B. B. .
PLACENTA, 2013, 34 (02) :201-203
[2]   Eculizumab fails to inhibit generation of C5a in vivo [J].
Burwick, Richard M. ;
Burwick, Nicholas R. ;
Feinberg, Bruce B. .
BLOOD, 2014, 124 (23) :3502-3503
[3]   Urinary Excretion of C5b-9 in Severe Preeclampsia Tipping the Balance of Complement Activation in Pregnancy [J].
Burwick, Richard M. ;
Fichorova, Raina N. ;
Dawood, Hassan Y. ;
Yamamoto, Hidemi S. ;
Feinberg, Bruce B. .
HYPERTENSION, 2013, 62 (06) :1040-1045
[4]   Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP [J].
Cataland, Spero R. ;
Holers, V. Michael ;
Geyer, Susan ;
Yang, Shangbin ;
Wu, Haifeng M. .
BLOOD, 2014, 123 (24) :3733-3738
[5]   Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS [J].
Cofiell, Roxanne ;
Kukreja, Anjli ;
Bedard, Krystin ;
Yan, Yan ;
Mickle, Angela P. ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Faas, Susan J. .
BLOOD, 2015, 125 (21) :3253-3262
[6]   Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn [J].
Hallstensen, Randi Fykse ;
Bergseth, Grethe ;
Foss, Stian ;
Jaeger, Steinar ;
Gedde-Dahl, Tobias ;
Holt, Jan ;
Christiansen, Dorte ;
Lau, Corinna ;
Brekke, Ole-Lars ;
Armstrong, Elina ;
Stefanovic, Vedran ;
Andersen, Jan Terje ;
Sandlie, Inger ;
Mollnes, Tom Eirik .
IMMUNOBIOLOGY, 2015, 220 (04) :452-459
[7]   Pathology after Eculizumab in Dense Deposit Disease and C3 GN [J].
Herlitz, Leal C. ;
Bomback, Andrew S. ;
Markowitz, Glen S. ;
Stokes, M. Barry ;
Smith, R. Neal ;
Colvin, Robert B. ;
Appel, Gerald B. ;
D'Agati, Vivette D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07) :1229-1237
[8]   Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo [J].
Volokhina, Elena B. ;
Bergseth, Grethe ;
van de Kar, Nicole C. A. J. ;
van den Heuvel, Lambertus P. ;
Mollnes, Tom Eirik .
BLOOD, 2015, 126 (02) :278-279
1